Omada Health, Inc. Common Stock (OMDA) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Omada Health, Inc. Common Stock stock (OMDA) is currently trading at $12.96. Omada Health, Inc. Common Stock PS ratio (Price-to-Sales) is 3.06. Analyst consensus price target for OMDA is $22.45. WallStSmart rates OMDA as Sell.
- OMDA PE ratio analysis and historical PE chart
- OMDA PS ratio (Price-to-Sales) history and trend
- OMDA intrinsic value — DCF, Graham Number, EPV models
- OMDA stock price prediction 2025 2026 2027 2028 2029 2030
- OMDA fair value vs current price
- OMDA insider transactions and insider buying
- Is OMDA undervalued or overvalued?
- Omada Health, Inc. Common Stock financial analysis — revenue, earnings, cash flow
- OMDA Piotroski F-Score and Altman Z-Score
- OMDA analyst price target and Smart Rating
Omada Health, Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Omada Health, Inc. Common Stock (OMDA) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in revenue growth, institutional own.. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
Omada Health, Inc. Common Stock (OMDA) Key Strengths (2)
Revenue surging 58.10% year-over-year
86.44% of shares held by major funds and institutions
Supporting Valuation Data
Omada Health, Inc. Common Stock (OMDA) Areas to Watch (6)
Company is destroying shareholder value
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Premium pricing at 3.5x book value
Small-cap company with higher risk but more growth potential
Revenue is fairly priced at 3.06x sales
Omada Health, Inc. Common Stock (OMDA) Detailed Analysis Report
Overall Assessment
This company scores 35/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 2.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Revenue Growth, Institutional Own.. Growth metrics are encouraging with Revenue Growth at 58.10%.
The Bear Case
The primary concerns are Return on Equity, Profit Margin, Operating Margin. Some valuation metrics including Price/Sales (3.06), Price/Book (3.47) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -8.68%, Operating Margin at 4.33%, Profit Margin at -4.91%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -8.68% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 58.10% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Profit Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
OMDA Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
OMDA's Price-to-Sales ratio of 3.06x trades 41% below its historical average of 5.16x (0th percentile). The current valuation is 63% below its historical high of 8.38x set in Oct 2025, and 0% above its historical low of 3.06x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~6.0x as trailing revenue scaled faster than the stock price.
Compare OMDA with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Omada Health, Inc. Common Stock (OMDA) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
Omada Health, Inc. Common Stock is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 260M with 58% growth year-over-year. The company is currently unprofitable, posting a -491.0% profit margin.
Key Findings
Revenue growing at 58% YoY, reaching 260M. This pace significantly outperforms most HEALTH INFORMATION SERVICES peers.
Generating 21M in free cash flow and 21M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -491.0% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Growth sustainability: can Omada Health, Inc. Common Stock maintain 58%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Omada Health, Inc. Common Stock.
Bottom Line
Omada Health, Inc. Common Stock is a high-conviction growth story with revenue accelerating at 58% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin -491.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Omada Health, Inc. Common Stock(OMDA)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
Omada Health, Inc. provides a range of virtual care programs in the United States. The company is headquartered in San Francisco, California.